AP NEWS

United States Restless Legs Syndrome Market and Competitive Landscape 2018-2023 - ResearchAndMarkets.com

October 12, 2018

DUBLIN--(BUSINESS WIRE)--Oct 12, 2018--The “US Restless Legs Syndrome Market and Competitive Landscape - 2018” report has been added to ResearchAndMarkets.com’s offering.

US Restless Legs Syndrome Market and Competitive Landscape - 2018, provides comprehensive insights into Restless Legs Syndrome pipeline, epidemiology, market valuations, product sales, market forecast, product forecasts, and market shares. This study accurately estimates and forecast Restless Legs Syndrome market size and drug sales. This research also provides insights into Restless Legs Syndrome epidemiology and late stage pipeline.

The research is classified into following sections - Restless Legs Syndrome overview with definitions, symptoms, etiology, diagnosis, treatment options; Restless Legs Syndrome pipeline insights covering late stage clinical trials pipeline; Restless Legs Syndrome prevalence trends by countries; Restless Legs Syndrome market size and forecast by countries, market events, trends; product sales and forecast by countries; market shares by countries.

Research Scope:

Restless Legs Syndrome pipeline: Find out the drugs in clinical trials for Restless Legs Syndrome by stages, phase 3 clinical trials, phase 2 clinical trials, and phase 1 clinical trials, by pharmacological class, by company Restless Legs Syndrome epidemiology: Find out the prevalence of Restless Legs Syndrome in US; prevalence forecast to 2023 Restless Legs Syndrome products: Identify key products marketed and prescribed for Restless Legs Syndrome by brand name, by molecule, by company, by branded / generic, in US Restless Legs Syndrome market size: Find out the market size for Restless Legs Syndrome drugs in US; Find out how the market advanced from 2014 Restless Legs Syndrome drug sales: Find out the sales of Restless Legs Syndrome drugs in US Restless Legs Syndrome drugs sales forecast: Sales forecast for Restless Legs Syndrome drugs to 2023 in US Restless Legs Syndrome market share analysis: Find out the market shares of Restless Legs Syndrome drugs and outlook in US

For more information about this report visit https://www.researchandmarkets.com/research/fmlk7r/united_states?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181012005186/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs

KEYWORD: UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 10/12/2018 07:39 AM/DISC: 10/12/2018 07:39 AM

http://www.businesswire.com/news/home/20181012005186/en

AP RADIO
Update hourly